Biotech

All Articles

Nuvation halts BET inhibitor after looking at stage 1 record

.After checking out at stage 1 record, Nuvation Biography has determined to halt work with its own o...

' Medical intuition' led FDA experts to support Zevra's rare disease med

.Zevra Therapies' unusual health condition drug seems to be to become on the course to confirmation ...

Pfizer takes $230M attacked after axing neglected DMD gene therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has gone a $230 thousan...

AC Immune sees 'site' prospective in Alzheimer's medicine data

.After more than twenty years of deal with neurodegenerative diseases, Swiss biotech air conditioner...

GSK drops ph. 2 HPV vaccination over shortage of best-in-class prospective

.GSK has actually broken up a phase 2 human papillomavirus (HPV) vaccine from its own pipeline after...

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.Operating system Therapies will specify on the NYSE American sell swap today via a $6.4 thousand IP...

ALX's fizzling CD47 response rate sends out stock spiraling down

.ALX Oncology's stage 2 gastric cancer cells response fee has actually weakened. After observing its...

Ionis centers eye ailment coming from aim ats of Roche-partnered possibility after records dissatisfy

.Another of Ionis Pharmaceuticals' vital midphase readouts has fallen short of expectations, trigger...

Biogen's CEO pointed out no risky sell 2023. He prepares to be strong

.While Biogen's pharma peers are actually seeking for late-stage possessions with little danger, CEO...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech seeking a pipe after it ditched its own lead ...